Washington, District of Columbia


Purpose:

The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions.


Study summary:

The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions. The goal of the Bronchiectasis Research Registry is to support collaborative research and assist in the planning of multi-center clinical trials for the treatment of NTM and non-CF Bronchiectasis, a progressive, non-curable disease of the lungs, which afflicts thousands of patients. The Registry will also be used to provide better insight into the study of the different types of Bronchiectasis, as well as the pathophysiology of the disorder. In 2012, in collaboration with NTM Info and Research, Inc (NTMir) and the consortium members, the COPD Foundation expanded the Bronchiectasis Research Registry to enroll patients with "non tuberculous mycobacteria (NTM) only". Prior to this time, the registry included individuals with Bronchiectasis, with or without NTM.


Criteria:

Inclusion Criteria: - Over the age of 18 - non-CF Bronchiectasis - Nontuberculosis Mycobacteria (NTM) Exclusion Criteria: - Under the age of 18 - CF Bronchiectasis


Study is Available At:


Original ID:

BRR


NCT ID:

NCT01822834


Secondary ID:


Study Acronym:


Brief Title:

Bronchiectasis and NTM Research Registry


Official Title:

Bronchiectasis and NTM Research Registry


Overall Status:

Recruiting


Study Phase:

N/A


Genders:

N/A


Minimum Age:

18 Years


Maximum Age:

120 Years


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

COPD Foundation


Oversight Authority:

United States: Western Institutional Review Board


Reasons Why Stopped:


Study Type:

Observational [Patient Registry]


Study Design:


Number of Arms:

0


Number of Groups:

2


Total Enrollment:

5000


Enrollment Type:

Anticipated


Overall Contact Information

Primary Contact:Elisha Malanga
1-866-731-2673 ext. 309
1-866-731-2673

Study Dates

Start Date:January 2008
Completion Date:December 2050
Completion Type:Anticipated
Primary Completion Date:December 2050
Primary Completion Type:Anticipated
Verification Date:January 2019
Last Changed Date:January 29, 2019
First Received Date:March 28, 2013

Study Outcomes

Outcome Type:Primary Outcome
Measure:Patient Recruitment and Data analysis
Time Frame:December 2050
Safety Issues:False
Description:The COPD Foundation expects to assist at least 4 researchers (with patient recruitment and/or data analysis) annually.

Study Interventions

There are no available Study Interventions

Study Arms

Study Arm Type:Other
Arm Name:Nontuberculosis Mycobacteria (NTM)
Description:Patients over the age of 18 with Nontuberculosis Mycobacteria (NTM)
Study Arm Type:Other
Arm Name:Non-CF Bronchiectasis Patients with or without NTM
Description:Patients over the age of 18 with non-CF Bronchiectasis with or without Nontuberculosis Mycobacteria (NTM).

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:COPD Foundation

Samples and Retentions

Study Population: Patients over the age of 18 with non-CF Bronchiectasis and/or Nontuberculosis Mycobacteria (NTM).
Sample Method:Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.